Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts ; volume:9 ; number:1 ; day:27 ; month:6 ; year:2010 ; pages:1-8 ; date:12.2010
Molecular cancer ; 9, Heft 1 (27.6.2010), 1-8, 12.2010
- Creator
-
Haubeiss, Silke
Schmid, Jens O.
Mürdter, Thomas E.
Sonnenberg, Maike
Friedel, Godehard
van der Kuip, Heiko
Aulitzky, Walter E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-9-168
- URN
-
urn:nbn:de:101:1-2021082421153891544979
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Haubeiss, Silke
- Schmid, Jens O.
- Mürdter, Thomas E.
- Sonnenberg, Maike
- Friedel, Godehard
- van der Kuip, Heiko
- Aulitzky, Walter E.
- SpringerLink (Online service)
Other Objects (12)
Biomarkers for cancer-associated fibroblasts
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer‐associated fibroblasts: activin A adds another string to their bow
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Biomarkers for cancer-associated fibroblasts
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer‐associated fibroblasts: activin A adds another string to their bow
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Biomarkers for cancer-associated fibroblasts
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer‐associated fibroblasts: activin A adds another string to their bow
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts